Ascensia Diabetes Care and Quattro Folia said today that the companies are partnering to combine Ascensia’s Contour Next One blood glucose monitoring system and Quattro Folia’s Balansio mobile insulin management app.
According to the deal, the Contour Next One meter will connect via Bluetooth to the Balansio mobile app and deliver blood glucose readings to the app’s insulin calculator.
Balansio is available in Finland, Sweden and the U.K., and the companies plan to launch their integrated product in other countries as soon as Balansio is available in those countries.
“We are delighted to partner with Quattro Folia and connect to their impressive and easy to use Balansio tool. Enabling people with diabetes who are using Balansio to have seamless access to remarkably accurate readings from the Contour Next One blood glucose monitoring system will help to support them in managing their insulin therapy,” Ascensia’s CEO, Michael Kloss, said in prepared remarks. “This partnership is another step towards integrated diabetes management. By connecting our system to their highly effective insulin calculator, we are further achieving our goal of simplifying and improving the lives of people with diabetes.”
Ascensia has its own mobile app, which collects and analyzes patient blood glucose readings delivered to it by the Contour Next One meter.
Quattro Folia’s Balansio app uses an algorithm to determine an optimal insulin dose based off of a user’s glucose readings and their carbohydrate intake. The app also collects physical activity data using its mobile platform.
“We are thrilled to be partnering with Ascensia to seamlessly connect our systems together to help individuals with diabetes take better care of themselves,” Quattro Folia CEO Harri Okkonen added. “There is a great need for effective bolus calculators, as we see that more than 50% of individuals with diabetes using multiple daily injection treatment do not know how to calculate their insulin dose correctly. Furthermore, Balansio helps patients by calculating daily A1c estimations. Continuous A1c trends give the individual and their healthcare professional timely feedback and can help the individual to understand how their current activities affect the balance of their long-term care.”
See the best minds in medtech live at DeviceTalks Boston on Oct. 2.
